Literature DB >> 2981140

Familial adult T-cell leukemia.

Y Miyamoto, K Yamaguchi, H Nishimura, K Takatsuki, T Motoori, M Morimatsu, T Yasaka, I Ohya, T Koga.   

Abstract

Two siblings who developed adult T-cell leukemia (ATL) are presented. The patient and 7 of 26 healthy family members examined had the serum antibodies against ATL-associated antigens (ATLA). This family study shows that two main routes of transmission of human T-cell leukemia virus (HTLV) may be involved: one is the route from parents to children and the other is horizontal transmission among spouses, especially from husband to wife; the anti-ATLA-positive family is considered to be a high-risk group for ATL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981140     DOI: 10.1002/1097-0142(19850101)55:1<181::aid-cncr2820550128>3.0.co;2-e

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Leukemogenesis of adult T-cell leukemia.

Authors:  Jun-ichirou Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 2.  Familial leukemias.

Authors:  Peter H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2015-02

Review 3.  Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL).

Authors:  Masao Matsuoka
Journal:  Retrovirology       Date:  2005-04-26       Impact factor: 4.602

Review 4.  Family Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic Review.

Authors:  Carolina Alvarez; Eduardo Gotuzzo; Anne-Mieke Vandamme; Kristien Verdonck
Journal:  Front Microbiol       Date:  2016-10-28       Impact factor: 5.640

5.  Adult T-cell leukemia in spouses.

Authors:  I Sanada; K Yamaguchi; M Yoshida; T Ishii; A Tsukamoto; M Sato; S Obata; T Shido
Journal:  Jpn J Cancer Res       Date:  1989-05

6.  Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Satoshi Nozuma; Eiji Matsuura; Toshio Matsuzaki; Osamu Watanabe; Ryuji Kubota; Shuji Izumo; Hiroshi Takashima
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.